| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a708524c0adee3eb5b130dac053f9c3d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-524
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-526
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-732
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-734
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-35 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-468
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2866 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46 |
| filingDate |
2019-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01647e5d94a4634d199c44271de49e8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e77ec5447e8c9e4ac29be2f962d9dbee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff9013ee682986dd244aab2c996835ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b628fbbf0f85adda66e60480146f7f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c50798b90428a4abb94d2577a7676c4 |
| publicationDate |
2021-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20210042324-A |
| titleOfInvention |
Compositions and methods related to CCR4 targeting engineered Fc-antigen binding domain constructs |
| abstract |
Fc-antigen binding constructs having a CCR4 binding domain and two or more Fc domains have been described as methods of using such constructs. The polypeptides that make up these constructs are also described. The Fc domain monomers included in the construct may include amino acid substitutions that promote homodimerization or heterodimerization. |
| priorityDate |
2018-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |